E-Prescribing Market - Insights for Business Growth Report 2024-2032

E-Prescribing Market Synopsis:

E-Prescribing Market Size Was Valued at USD 3.66 Billion in 2023, and is Projected to Reach USD 31.05 Billion by 2032, Growing at a CAGR of 26.80% From 2024-2032.

E-prescribing, also referred to as electronic prescribing, is a technological structure that allows doctors and other prescribers to electronically write prescriptions that are sent to a participating pharmacy instead of handwritten orders, facsimile, or voice, transmittals. E-prescribing or electronic prescribing is a type of application that implemented commonly through web or cloud that enables the provider to prescribe electronically. It is a computer-generated and computer-delivered process of producing and transmitting correct prescription orders to a hospital-based or any independent pharmacy. Electronic prescription software is capable of renewing prescription and analyzing a patient’s medication history and prescribing appropriate medicaments and software compatibility with the EMR.

The e-prescribing market has grown significantly over the years because of technological advancement and the advancement of the adoption of Electronic Health Record/ Electronic Medical Record, the need to lower on avoidable incidences of medication error, and an overall move towards efficient Health Information Technology systems. E-prescribing refers to a practice whereby prescriptions are transmitted through an electronic system to the pharmacist with a view of enhancing the tradition of handling prescriptions electronically. Increased incidence of chronic ailments together with the increasing aging population has played a major role in the growth of this market. Such demographic factors have plunged the consumption of healthcare services hence raising the importance of efficient prescription systems. Further, it has been seen that ministries of health and government driven strategies and rules all over the world especially the Health Information Technology for Economic and Clinical Health (HITECH) Act within the United States of America and similar policies within European nations have greatly contributed to the contemporary use of e-prescribing systems.

The market’s growth is also attributed to the development of heath IT infrastructure such as the integration of e-prescribing solutions with EHRs and CDSs. This integration does not only benefits the patients but the heath care providers since it increases effectiveness of patient care delivery. In addition, to the COVID-19 outbreak, increased the importance of telehealth services and safe and convenient necessity for e-prescribing than paper prescriptions. Nonetheless, the market has its pitfalls like the industry’s anxiety about data security, and the enormous cost of adopting e-prescribing solutions. Nonetheless, existing challenges of high implementation cost, complexity, and lack of standardisation, coupled with continued technological advancements and increasing appreciation of e-prescribing are expected to reduce the impact of these barriers to preserve the future market growth.

E-Prescribing Market Trend Analysis:

Widespread Adoption of E-Prescribing Systems and Enhanced Data Integration

• Another dynamic in the e-prescribing market is where e-prescribing systems is gradually making its way into healthcare facilities. Prescription ordering systems enable the healthcare providers to electronically communicate the prescriptions to the pharmacies eliminating the use of prescription writing and passing. The use of such a digital approach means that the amount of prescription work done is greatly reduced by eliminating the time spent completing paperwork, entering data into a computer, or handwriting prescriptions. The above errors find their way eliminated by e-prescribing and in the same process, patient safety and efficiency in the operation of the health sector, particularly the readiness of the pharmacy becomes a reality.
• besides, operational with respect to well-established revenue streams, there is growing attention to the interconnectivity of patient data across health systems, which are fueling e-prescribing solutions that must remain interoperable with EHRs. At this level of interoperability, care is experienced since client’s full medical record and current medication history can be seen in real time by other practitioners involved in his/her care. It has also been argued that such integration enhances medication dispensing detail, minimises potential drug indications, and assists in the formulation of superior clinical decisions thus promoting quality care.

Advancements Driven by EHR Adoption and Government Initiatives in the E-Prescribing Market

• The expansion of electronic health records (EHR) is probably one of the biggest factors that has the potential to influence the e-prescribing market space in the future. EHRs have now become imperative for the healthcare providers due to its use in the simple collection and management of patients’ details making the general organization of healthcare solutions better. The interfacing of e-prescribing systems with EHRs provides automated prescription functions making efficient prescription processes and minimizes the occurrence of prescription errors, increases safer patient care and the existing and efficient communication between care professionals, and pharmacy. Services such as e-prescribing are more in demand now since clinics and other health-care facilities are adopting more electronic technologies for their use and e-prescribing being complementary to EHRs make the market for its vendors highly promising.
• Also, the increasing number of government support and policies to implement the healthcare industry, mostly in the U.S, Europe, and some Asiatic countries, are also complementing the demand of the e-prescribing solutions. Currently, most governments are implementing polices that promote the conversion from paper based prescriptions to electronic systems that enhance the health care systems. Apart from encouraging higher levels of performance and precision in prescribing activities, these interventions pave new opportunities for e-prescribing vendors targeting to enhance their standing in the marketplace. With the growth of demand for fully-fledged digital health-care systems, e-prescribing companies have a chance to integrate their next solutions in compliance with these regulations and respond to the tendencies of increasing digitalization of health-care systems.

E-Prescribing Market Segment Analysis:

E-Prescribing Market Segmented on the basis of Product, Component, Type of System, By Usage Mode, Mode of Delivery, Substances, Specialties, End-User, and Region

By Product, Solutions segment is expected to dominate the market during the forecast period

• Products in the medication management market are mainly focused on the software-based solutions for making medication processes more effective and safer. These solutions include for instance electronic prescribing e-prescribing solutions where practitioners are in a position of writing prescriptions that are electronically sent to the pharmacy thereby reducing the chances of medical errors. Furthermore, medication reconciliation software has another function in identifying and correcting medication order discrepancies for the hospitalized patient, especially in setting cross-cover, admitting and discharge cases. These solutions’ implementation has made work more manageable and has helped to improve the working relationship between practitioners and pharmacists in ways that will benefit patients.
• The growing concern for reducing the cases of medication errors is another factor that is contributing for the use of such software solutions in care centers especially in hospital and pharmacies. Since mediations regimens are becoming more complicated there is a likelihood that errors will be made when prescribing or administering the drugs. Solutions for medication management are intended to cover such problems by offering means to help a clinical decision, for example, alerts for drug interactions or allergies. As the culture of patient safety and quality healthcare has been adopted in healthcare systems, health facility’s most purchase sophisticated medication dispensing systems to reduce on wrong prescription and ensure the patient gets right medicine at the right time.

By End-User, Clinics segment expected to held the largest share

• It has emerged that medication management system is becoming more popular in small clinics since it assists the firms to organise the patients’ prescription data in an efficient manner. These systems allow patient medication histories, prescription, and management of prescription refilling and other related activities to be done within integrated interfaces. Reducing the amoung of paperwork required for prescriptioning helps clinics free up staff time and decreases the time required to fill prescriptions for for patients. It also improves patient satisfaction in a way that enables health-care professionals to spend time more directly serving patient consultations.
• Besides enhancing management to increase operational efficiency, the medication management systems provide better patient care in small clinics by enhancing accurate and early medication administration. Such systems offer one or more clinical decision support tools to the clinicians where they are informed when there are drug interactions or an allergy before a prescription is made. This functionality is specifically useful to health care professionals who admin a small clinic, this may mean that they do not have an easy access to a full pharmacy service. In addition, proper medication management leads to improved understanding and compliance with the use of medication by clinic patients as well as enhances positive patient relations between the clinic staff and the patient.

E-Prescribing Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• On a regional level, North America especially the United States has recorded outstanding growth of the E-Prescribing through positive government policies including the HITECH Act and MACRA. These policies encourage the use of E-Prescribing system solutions among the health care service providers and have led to adoption of these systems by almost all the hospitals, clinics, Pharmacy and drug stores. A system which replaces the paper-based prescriptions makes the chance of making errors small hence enhance the safety of patients and enhance the efficiency of the prescribers. The increasing concerns for accurate medication administration and the need to improve the general operational efficiency has provided the necessary conditions for implementation of E-Prescribing systems in this area.
• Further, the solid existing healthcare system in the U.S. and the availability of key industry players including Cerner Corporation, Allscripts Healthcare Solutions, and Epic Systems boosted the market progression. These vendors even have sophisticated E-Prescribing software which are compatible with the EHR, this enhances the co-ordination of care and the final results which are obtained. The rarity of chronic diseases results in the need for patient medication regimens to be constantly adjusted, and with the help of E-Prescribing platforms this becomes easier. Ongoing healthcare provider’s strive in attaining effective operational efficiency as well as minimization of risks involved with prescription medication results in North America to lead the E-Prescribing market globally.

Active Key Players in the E-Prescribing Market:

• Epic Systems Corporation (U.S.)
• Cerner Corporation (U.S.)
• Allscripts Healthcare, LLC. (U.S.)
• NXGN Management, LLC. (U.S.)
• athenahealth, Inc. (U.S.)
• RelayHealth, LLC (U.S.)
• Henry Schein, Inc. (U.S.)
• General electric (U.S.)
• CPSI (U.S.)
• DrFirst (U.S.)
• Medical Information Technology, Inc. (U.S.)
• eClinicalWorks (U.S.), and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: E-Prescribing Market by Product
 4.1 E-Prescribing Market Snapshot and Growth Engine
 4.2 E-Prescribing Market Overview
 4.3 Solutions
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Solutions: Geographic Segmentation Analysis
 4.4 Services
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Services: Geographic Segmentation Analysis

Chapter 5: E-Prescribing Market by Component
 5.1 E-Prescribing Market Snapshot and Growth Engine
 5.2 E-Prescribing Market Overview
 5.3 Hardware
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Hardware: Geographic Segmentation Analysis
 5.4 Software
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Software: Geographic Segmentation Analysis
 5.5 and Services
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 and Services: Geographic Segmentation Analysis

Chapter 6: E-Prescribing Market by Type of System
 6.1 E-Prescribing Market Snapshot and Growth Engine
 6.2 E-Prescribing Market Overview
 6.3 Stand-alone E-prescribing System and Integrated E-prescribing System
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Stand-alone E-prescribing System and Integrated E-prescribing System: Geographic Segmentation Analysis

Chapter 7: E-Prescribing Market by Usage Mode
 7.1 E-Prescribing Market Snapshot and Growth Engine
 7.2 E-Prescribing Market Overview
 7.3 Handheld Device
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Handheld Device: Geographic Segmentation Analysis
 7.4 Computer-Based Devices
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Computer-Based Devices: Geographic Segmentation Analysis

Chapter 8: E-Prescribing Market by Mode of Delivery
 8.1 E-Prescribing Market Snapshot and Growth Engine
 8.2 E-Prescribing Market Overview
 8.3 Web and Cloud-Based Solutions
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Web and Cloud-Based Solutions: Geographic Segmentation Analysis
 8.4 On-Premise Solutions
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 On-Premise Solutions: Geographic Segmentation Analysis

Chapter 9: E-Prescribing Market by Substances
 9.1 E-Prescribing Market Snapshot and Growth Engine
 9.2 E-Prescribing Market Overview
 9.3 Controlled Substances
  9.3.1 Introduction and Market Overview
  9.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  9.3.3 Key Market Trends, Growth Factors and Opportunities
  9.3.4 Controlled Substances: Geographic Segmentation Analysis
 9.4 Non-Controlled Substances
  9.4.1 Introduction and Market Overview
  9.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  9.4.3 Key Market Trends, Growth Factors and Opportunities
  9.4.4 Non-Controlled Substances: Geographic Segmentation Analysis

Chapter 10: E-Prescribing Market by Specialties
 10.1 E-Prescribing Market Snapshot and Growth Engine
 10.2 E-Prescribing Market Overview
 10.3 Oncology
  10.3.1 Introduction and Market Overview
  10.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.3.3 Key Market Trends, Growth Factors and Opportunities
  10.3.4 Oncology: Geographic Segmentation Analysis
 10.4 Sports Medicine
  10.4.1 Introduction and Market Overview
  10.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.4.3 Key Market Trends, Growth Factors and Opportunities
  10.4.4 Sports Medicine: Geographic Segmentation Analysis
 10.5 Neurology
  10.5.1 Introduction and Market Overview
  10.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.5.3 Key Market Trends, Growth Factors and Opportunities
  10.5.4 Neurology: Geographic Segmentation Analysis
 10.6 Cardiology
  10.6.1 Introduction and Market Overview
  10.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.6.3 Key Market Trends, Growth Factors and Opportunities
  10.6.4 Cardiology: Geographic Segmentation Analysis
 10.7 Others)
  10.7.1 Introduction and Market Overview
  10.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.7.3 Key Market Trends, Growth Factors and Opportunities
  10.7.4 Others): Geographic Segmentation Analysis
 10.8 End-User (Clinics
  10.8.1 Introduction and Market Overview
  10.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.8.3 Key Market Trends, Growth Factors and Opportunities
  10.8.4 End-User (Clinics: Geographic Segmentation Analysis
 10.9 Physicians
  10.9.1 Introduction and Market Overview
  10.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.9.3 Key Market Trends, Growth Factors and Opportunities
  10.9.4 Physicians: Geographic Segmentation Analysis
 10.10 Pharmacies
  10.10.1 Introduction and Market Overview
  10.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.10.3 Key Market Trends, Growth Factors and Opportunities
  10.10.4 Pharmacies: Geographic Segmentation Analysis
 10.11 Hospitals
  10.11.1 Introduction and Market Overview
  10.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  10.11.3 Key Market Trends, Growth Factors and Opportunities
  10.11.4 Hospitals: Geographic Segmentation Analysis

Chapter 11: Company Profiles and Competitive Analysis
 11.1 Competitive Landscape
  11.1.1 Competitive Benchmarking
  11.1.2 E-Prescribing Market Share by Manufacturer (2023)
  11.1.3 Industry BCG Matrix
  11.1.4 Heat Map Analysis
  11.1.5 Mergers and Acquisitions  
 11.2 EPIC SYSTEMS CORPORATION (U.S.)
  11.2.1 Company Overview
  11.2.2 Key Executives
  11.2.3 Company Snapshot
  11.2.4 Role of the Company in the Market
  11.2.5 Sustainability and Social Responsibility
  11.2.6 Operating Business Segments
  11.2.7 Product Portfolio
  11.2.8 Business Performance
  11.2.9 Key Strategic Moves and Recent Developments
  11.2.10 SWOT Analysis
 11.3 CERNER CORPORATION (U.S.)
 11.4 ALLSCRIPTS HEALTHCARE LLC. (U.S.)
 11.5 NXGN MANAGEMENT LLC. (U.S.)
 11.6 ATHENAHEALTH INC. (U.S.)
 11.7 RELAYHEALTH LLC (U.S.)
 11.8 HENRY SCHEIN INC. (U.S.)
 11.9 GENERAL ELECTRIC (U.S.)
 11.10 CPSI (U.S.)
 11.11 DRFIRST (U.S.)
 11.12 MEDICAL INFORMATION TECHNOLOGY INC. (U.S.)
 11.13 ECLINICALWORKS (U.S.)
 11.14 OTHER ACTIVE PLAYERS

Chapter 12: Global E-Prescribing Market By Region
 12.1 Overview
 12.2. North America E-Prescribing Market
  12.2.1 Key Market Trends, Growth Factors and Opportunities
  12.2.2 Top Key Companies
  12.2.3 Historic and Forecasted Market Size by Segments
  12.2.4 Historic and Forecasted Market Size By Product
  12.2.4.1 Solutions
  12.2.4.2 Services
  12.2.5 Historic and Forecasted Market Size By Component
  12.2.5.1 Hardware
  12.2.5.2 Software
  12.2.5.3 and Services
  12.2.6 Historic and Forecasted Market Size By Type of System
  12.2.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.2.7 Historic and Forecasted Market Size By Usage Mode
  12.2.7.1 Handheld Device
  12.2.7.2 Computer-Based Devices
  12.2.8 Historic and Forecasted Market Size By Mode of Delivery
  12.2.8.1 Web and Cloud-Based Solutions
  12.2.8.2 On-Premise Solutions
  12.2.9 Historic and Forecasted Market Size By Substances
  12.2.9.1 Controlled Substances
  12.2.9.2 Non-Controlled Substances
  12.2.10 Historic and Forecasted Market Size By Specialties
  12.2.10.1 Oncology
  12.2.10.2 Sports Medicine
  12.2.10.3 Neurology
  12.2.10.4 Cardiology
  12.2.10.5 Others)
  12.2.10.6 End-User (Clinics
  12.2.10.7 Physicians
  12.2.10.8 Pharmacies
  12.2.10.9 Hospitals
  12.2.11 Historic and Forecast Market Size by Country
  12.2.11.1 US
  12.2.11.2 Canada
  12.2.11.3 Mexico
 12.3. Eastern Europe E-Prescribing Market
  12.3.1 Key Market Trends, Growth Factors and Opportunities
  12.3.2 Top Key Companies
  12.3.3 Historic and Forecasted Market Size by Segments
  12.3.4 Historic and Forecasted Market Size By Product
  12.3.4.1 Solutions
  12.3.4.2 Services
  12.3.5 Historic and Forecasted Market Size By Component
  12.3.5.1 Hardware
  12.3.5.2 Software
  12.3.5.3 and Services
  12.3.6 Historic and Forecasted Market Size By Type of System
  12.3.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.3.7 Historic and Forecasted Market Size By Usage Mode
  12.3.7.1 Handheld Device
  12.3.7.2 Computer-Based Devices
  12.3.8 Historic and Forecasted Market Size By Mode of Delivery
  12.3.8.1 Web and Cloud-Based Solutions
  12.3.8.2 On-Premise Solutions
  12.3.9 Historic and Forecasted Market Size By Substances
  12.3.9.1 Controlled Substances
  12.3.9.2 Non-Controlled Substances
  12.3.10 Historic and Forecasted Market Size By Specialties
  12.3.10.1 Oncology
  12.3.10.2 Sports Medicine
  12.3.10.3 Neurology
  12.3.10.4 Cardiology
  12.3.10.5 Others)
  12.3.10.6 End-User (Clinics
  12.3.10.7 Physicians
  12.3.10.8 Pharmacies
  12.3.10.9 Hospitals
  12.3.11 Historic and Forecast Market Size by Country
  12.3.11.1 Russia
  12.3.11.2 Bulgaria
  12.3.11.3 The Czech Republic
  12.3.11.4 Hungary
  12.3.11.5 Poland
  12.3.11.6 Romania
  12.3.11.7 Rest of Eastern Europe
 12.4. Western Europe E-Prescribing Market
  12.4.1 Key Market Trends, Growth Factors and Opportunities
  12.4.2 Top Key Companies
  12.4.3 Historic and Forecasted Market Size by Segments
  12.4.4 Historic and Forecasted Market Size By Product
  12.4.4.1 Solutions
  12.4.4.2 Services
  12.4.5 Historic and Forecasted Market Size By Component
  12.4.5.1 Hardware
  12.4.5.2 Software
  12.4.5.3 and Services
  12.4.6 Historic and Forecasted Market Size By Type of System
  12.4.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.4.7 Historic and Forecasted Market Size By Usage Mode
  12.4.7.1 Handheld Device
  12.4.7.2 Computer-Based Devices
  12.4.8 Historic and Forecasted Market Size By Mode of Delivery
  12.4.8.1 Web and Cloud-Based Solutions
  12.4.8.2 On-Premise Solutions
  12.4.9 Historic and Forecasted Market Size By Substances
  12.4.9.1 Controlled Substances
  12.4.9.2 Non-Controlled Substances
  12.4.10 Historic and Forecasted Market Size By Specialties
  12.4.10.1 Oncology
  12.4.10.2 Sports Medicine
  12.4.10.3 Neurology
  12.4.10.4 Cardiology
  12.4.10.5 Others)
  12.4.10.6 End-User (Clinics
  12.4.10.7 Physicians
  12.4.10.8 Pharmacies
  12.4.10.9 Hospitals
  12.4.11 Historic and Forecast Market Size by Country
  12.4.11.1 Germany
  12.4.11.2 UK
  12.4.11.3 France
  12.4.11.4 The Netherlands
  12.4.11.5 Italy
  12.4.11.6 Spain
  12.4.11.7 Rest of Western Europe
 12.5. Asia Pacific E-Prescribing Market
  12.5.1 Key Market Trends, Growth Factors and Opportunities
  12.5.2 Top Key Companies
  12.5.3 Historic and Forecasted Market Size by Segments
  12.5.4 Historic and Forecasted Market Size By Product
  12.5.4.1 Solutions
  12.5.4.2 Services
  12.5.5 Historic and Forecasted Market Size By Component
  12.5.5.1 Hardware
  12.5.5.2 Software
  12.5.5.3 and Services
  12.5.6 Historic and Forecasted Market Size By Type of System
  12.5.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.5.7 Historic and Forecasted Market Size By Usage Mode
  12.5.7.1 Handheld Device
  12.5.7.2 Computer-Based Devices
  12.5.8 Historic and Forecasted Market Size By Mode of Delivery
  12.5.8.1 Web and Cloud-Based Solutions
  12.5.8.2 On-Premise Solutions
  12.5.9 Historic and Forecasted Market Size By Substances
  12.5.9.1 Controlled Substances
  12.5.9.2 Non-Controlled Substances
  12.5.10 Historic and Forecasted Market Size By Specialties
  12.5.10.1 Oncology
  12.5.10.2 Sports Medicine
  12.5.10.3 Neurology
  12.5.10.4 Cardiology
  12.5.10.5 Others)
  12.5.10.6 End-User (Clinics
  12.5.10.7 Physicians
  12.5.10.8 Pharmacies
  12.5.10.9 Hospitals
  12.5.11 Historic and Forecast Market Size by Country
  12.5.11.1 China
  12.5.11.2 India
  12.5.11.3 Japan
  12.5.11.4 South Korea
  12.5.11.5 Malaysia
  12.5.11.6 Thailand
  12.5.11.7 Vietnam
  12.5.11.8 The Philippines
  12.5.11.9 Australia
  12.5.11.10 New Zealand
  12.5.11.11 Rest of APAC
 12.6. Middle East & Africa E-Prescribing Market
  12.6.1 Key Market Trends, Growth Factors and Opportunities
  12.6.2 Top Key Companies
  12.6.3 Historic and Forecasted Market Size by Segments
  12.6.4 Historic and Forecasted Market Size By Product
  12.6.4.1 Solutions
  12.6.4.2 Services
  12.6.5 Historic and Forecasted Market Size By Component
  12.6.5.1 Hardware
  12.6.5.2 Software
  12.6.5.3 and Services
  12.6.6 Historic and Forecasted Market Size By Type of System
  12.6.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.6.7 Historic and Forecasted Market Size By Usage Mode
  12.6.7.1 Handheld Device
  12.6.7.2 Computer-Based Devices
  12.6.8 Historic and Forecasted Market Size By Mode of Delivery
  12.6.8.1 Web and Cloud-Based Solutions
  12.6.8.2 On-Premise Solutions
  12.6.9 Historic and Forecasted Market Size By Substances
  12.6.9.1 Controlled Substances
  12.6.9.2 Non-Controlled Substances
  12.6.10 Historic and Forecasted Market Size By Specialties
  12.6.10.1 Oncology
  12.6.10.2 Sports Medicine
  12.6.10.3 Neurology
  12.6.10.4 Cardiology
  12.6.10.5 Others)
  12.6.10.6 End-User (Clinics
  12.6.10.7 Physicians
  12.6.10.8 Pharmacies
  12.6.10.9 Hospitals
  12.6.11 Historic and Forecast Market Size by Country
  12.6.11.1 Turkiye
  12.6.11.2 Bahrain
  12.6.11.3 Kuwait
  12.6.11.4 Saudi Arabia
  12.6.11.5 Qatar
  12.6.11.6 UAE
  12.6.11.7 Israel
  12.6.11.8 South Africa
 12.7. South America E-Prescribing Market
  12.7.1 Key Market Trends, Growth Factors and Opportunities
  12.7.2 Top Key Companies
  12.7.3 Historic and Forecasted Market Size by Segments
  12.7.4 Historic and Forecasted Market Size By Product
  12.7.4.1 Solutions
  12.7.4.2 Services
  12.7.5 Historic and Forecasted Market Size By Component
  12.7.5.1 Hardware
  12.7.5.2 Software
  12.7.5.3 and Services
  12.7.6 Historic and Forecasted Market Size By Type of System
  12.7.6.1 Stand-alone E-prescribing System and Integrated E-prescribing System
  12.7.7 Historic and Forecasted Market Size By Usage Mode
  12.7.7.1 Handheld Device
  12.7.7.2 Computer-Based Devices
  12.7.8 Historic and Forecasted Market Size By Mode of Delivery
  12.7.8.1 Web and Cloud-Based Solutions
  12.7.8.2 On-Premise Solutions
  12.7.9 Historic and Forecasted Market Size By Substances
  12.7.9.1 Controlled Substances
  12.7.9.2 Non-Controlled Substances
  12.7.10 Historic and Forecasted Market Size By Specialties
  12.7.10.1 Oncology
  12.7.10.2 Sports Medicine
  12.7.10.3 Neurology
  12.7.10.4 Cardiology
  12.7.10.5 Others)
  12.7.10.6 End-User (Clinics
  12.7.10.7 Physicians
  12.7.10.8 Pharmacies
  12.7.10.9 Hospitals
  12.7.11 Historic and Forecast Market Size by Country
  12.7.11.1 Brazil
  12.7.11.2 Argentina
  12.7.11.3 Rest of SA

Chapter 13 Analyst Viewpoint and Conclusion
13.1 Recommendations and Concluding Analysis
13.2 Potential Market Strategies

Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research